Term ends Sep 6, 2032 · High confidence
20-year base term ends Oct 27, 2029
Held by Boston Scientific Scimed, Inc.
Filed Oct 27, 2009 as application 12/606,758 · Granted Feb 3, 2015
Base term plus 1045 days of patent term adjustment (USPTO delay)
Today
2009
2032
Clock starts
Oct 27, 2009
Oct 27, 2009
Term ends
Sep 6, 2032
Sep 6, 2032
Granted
Feb 3, 2015
Feb 3, 2015
base term
patent term adjustment
fee events
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,045
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1045 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 27, 2009, when this application, 12/606,758, was filed | Oct 27, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1045 days, USPTO patent term adjustment record | Sep 6, 2032 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 6, 2032 | High confidence |
This family
| US 8,944,990 | this patent Sep 2032 | Sep 2032 |
| US 10,357,284 | In force no later than Oct 2029 | no later than Oct 2029 |
| US D733,298 | In force Jun 2029 | Jun 2029 |
| US D775,729 | In force Jan 2032 | Jan 2032 |
| US 10,398,431 | In force Aug 2030 | Aug 2030 |
| US 12,310,623 | In force May 2031 | May 2031 |
| Application 19/016,750 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 14, 2010 Reel 23782, frame 643 | Ogdahl, Jason W. | AMS Research Corporation | Assignment of Assignor's Interest |
| Jan 14, 2010 Reel 23782, frame 696 | Hamel, Kory P.; Buysman, John Jason; Alexander, James A.; Mujwid, James R.; Otte, John F. | AMS Research Corporation | Assignment of Assignor's Interest |
| Jul 22, 2011 Reel 26632, frame 535 | AMS Research Corporation | Morgan Stanley Senior Funding, Inc., as Administrative Agent | Security Agreement |
| Mar 3, 2014 Reel 32380, frame 53 | Morgan Stanley Senior Funding, Inc., as Administrative Agent | AMS Research Corporation | Release of Patent Security Interest |
| Mar 20, 2014 Reel 32491, frame 440 | Endo Pharmaceuticals Solutions, Inc.; Endo Pharmaceuticals, Inc.; AMS Research Corporation; American Medical Systems, Inc.; Laserscope | Deutsche Bank AG New York Branch, as Collateral Agent | Grant of Security Interest in Patents |
| Aug 6, 2015 Reel 36285, frame 146 | Deutsche Bank AG New York Branch | American Medical Systems, LLC; AMS Research, LLC; Laserscope | Release of Security Interest |
| Aug 6, 2015 reel/frame not recorded | Deutsche Bank AG New York Branch | American Medical Systems, LLC | Release of Security Interest |
| Aug 6, 2015 reel/frame not recorded | Deutsche Bank AG New York Branch | AMS Research, LLC | Release of Security Interest |
| Aug 6, 2015 reel/frame not recorded | Deutsche Bank AG New York Branch | Laserscope | Release of Security Interest |
| Dec 15, 2015 Reel 37300, frame 199 | AMS Research Corpation | AMS Research, LLC | Change of Name |
| Jan 11, 2016 Reel 37473, frame 745 | AMS Research, LLC | Aphrodite Women's Health, LLC | Assignment of Assignor's Interest |
| Jan 11, 2016 Reel 37473, frame 919 | Aphrodite Women's Health, LLC | Astora Women's Health, LLC | Change of Name |
| Feb 25, 2016 Reel 37916, frame 28 | AMS Research Corporation | AMS Research, LLC | Corrective Assignment to Correct the Conveying Party Data; Previously Recorded on Reel 037300 Frame 0199. Assignor(S) Hereby Confirms the Change of Name. |
| Jun 8, 2017 Reel 42743, frame 278 | Astora Women's Health, LLC | Wilmington Trust, National Association, as Collateral Trustee | Security Interest |
| Sep 7, 2017 Reel 43778, frame 302 | Astora Women's Health, LLC; Endo Health Solutions Inc.; Astora Women's Health Holdings, LLC | Boston Scientific Corporation | Assignment of Assignor's Interest |
| Sep 7, 2017 Reel 43780, frame 316 | Boston Scientific Corporation | Boston Scientific Scimed, Inc. | Assignment of Assignor's Interest |
| Apr 26, 2024 Reel 67240, frame 1 | Wilmington Trust, National Association | Actient Pharmaceuticals LLC; Astora Women’s Health Holdings, LLC; Astora Women’s Health LLC; Auxilium Pharmaceuticals, LLC; Auxilium US Holdings, LLC; BioSpecifics Technologies Corp.; BioSpecifics Technologies LLC; Dava International, LLC; Dava Pharmaceuticals, LLC; Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.); Endo Pharmaceuticals Inc.; Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.); Generics Bidco I, LLC; Generics International (US), Inc.; Par Pharmaceutical, Inc.; Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC); Quartz Specialty Pharmaceuticals, LLC; Slate Pharmaceuticals, LLC; Vintage Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Actient Pharmaceuticals LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium US Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies Corp. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava International, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics Bidco I, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics International (US), Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Pharmaceutical, Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Quartz Specialty Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Slate Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Vintage Pharmaceuticals, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Sep 2032
Term ends Sep 6, 2032. No further fees fall due before then
Note
The 1045 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
59
later US patents cite this one
That is top 10% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.